Clinical trial
Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy
NCT00293644 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00293644 |
|---|---|
| Title | Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy |
| Official title | A Randomized, Open-Label, Study of Pre-emptive Diclectin® Treatment for Severe Nausea and Vomiting of Pregnancy |
| Lead sponsor | The Hospital for Sick Children, Other |
| Collaborators | Duchesnay Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperemesis Gravidarum, Pregnancy |
| Intervention type | Drug |
| Interventions | Diclectin® |
| Enrollment | 76 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2015 |
| First posted | Feb 17, 2006 |
| Last update posted | Jul 22, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: